Patent Awarded for Saliva-Based Test to Help Diagnose Concussion

💡 This post was automatically imported from HIT Consultant. You can find the original article here.
Author: HIT Consultant Media (Fred Pennic)

Patent Awarded for Saliva-Based Test to Help Diagnose Concussion
Pictured is Quadrant’s Clarifi™ mTBI Saliva Test collection device, which is in the research and development phase

What You Should Know:

Quadrant Biosciences announced today that the U.S. Patent and Trademark Office (USPTO) has awarded the company and two of its academic partners, the State University of New York Research Foundation and the Penn State Research Foundation, with U.S. Patent No.11,453,914 for the analysis and prediction of mild traumatic brain injury (mTBI) and concussion symptoms.

– This research was first mentioned on CNN back in 2017. This patent is a transformative piece of intellectual property that Quadrant is using to develop its Clarifi™ mTBI Saliva Test, expected to be available in late 2023. Quadrant has started discussions about potentially licensing this technology to third-parties. This test uses small non-coding RNAs found in the saliva to help diagnose concussions.

The News Aggregator will pull the latest articles and news from around the internet to present them in one place for you to easily keep up to date on all things related to Medical Informatics.

You may also like...

Welcome to MediFormatica. The site is still under construction so there are some rough edges here and there, but I'll be adding new and exciting content every day. So enjoy it and come back again for more great stuff.

X